par Dinh, Phuong 
;Tomasello, Gianluca ;Piccart-Gebhart, Martine
Référence Management of Breast Diseases, Springer Berlin Heidelberg, page (373-389)
Publication Publié, 2010
;Tomasello, Gianluca ;Piccart-Gebhart, Martine Référence Management of Breast Diseases, Springer Berlin Heidelberg, page (373-389)
Publication Publié, 2010
Partie d'ouvrage collectif
| Résumé : | Up to 25% of women with breast cancer have tumors, which are human epidermal growth factor receptor-2 (HER2) positive, associated with an aggressive phenotype, higher recurrence rate and reduced survival [1, 2]. In these patients with poorer prognosis, combination chemotherapy (±endocrine therapy), up until recently, was the only treatment modality available. © 2010 Springer Berlin Heidelberg. |
